Clinical Trial Update: Topical Diclofenac on Macular Thickness After Phacoemulsification [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating topical diclofenac to assess macular thickness after cataract surgery in patients with diabetic eye disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Diabetic Retinopathy

Drugs mentioned

• Diclofenac topical (diclofenac)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Diabetic Oculopathy | Phase 2 | Status: UNKNOWN